Skip to content

Clinical trials

Shock, Septic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Septic Country / region: Italy Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20062
20075
20083
20091
20101
20112
20121
20132
20152
20163
20173
20183
20196
20205
20223
20231
20241
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Unknown status10
Recruiting4
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Roma La Sapienza8
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico4
Università Politecnica delle Marche4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Humanitas Clinical and Research Center3
Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva2
University of Turin, Italy2
Anders Perner, MD, PhD1
Andrea Morelli1
Azienda Ospedaliero, Universitaria Pisana1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Septic53
Sepsis29
Critical Illness6
Diabetes Insipidus3
Infections3
Shock, Cardiogenic3
Respiratory Distress Syndrome2
Tachycardia2
Acid-Base Imbalance1
Acidosis, Respiratory1

Trials

Showing 76 to 53 of 53. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.